BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 20, 2014
View Archived Issues
New cost-effective, easy-to-perform, point-of-care tests for the diagnosis of malaria
Read More
Takeda presents phase III results for TAK-438
Read More
NeoStem signs licensing agreement with Cellular Biomedicine for DC-TC
Read More
Otsuka Pharmaceutical profiles pipeline progress of fourth quarter of fiscal 2013
Read More
Gene transfer trial for spinal muscular atrophy type 1 begins patient recruitment
Read More
AstraZeneca to collaborate with UK Medical Research Council's Laboratory of Molecular Biology
Read More
Lipocine reports phase I data for pre-term birth product candidate LPCN-1107
Read More
Hemispherx Biopharma enters collaboration to test Alferon N Injection in Tamiflu-resistant strains
Read More
Adalimumab receives FDA orphan drug status for uveitis
Read More
MK-2206/ridaforolimus combination active in advanced breast cancer
Read More
NCL-1 impairs prostate cancer growth in vivo
Read More
Tetra Discovery Partners patents new PDE4 inhibitors
Read More
Merck & Co. synthesizes novel sodium channel blockers
Read More
Selinexor receives orphan drug designation for acute myeloid leukemia
Read More
HHS presents adoptive cell transfer-based cancer immunotherapy
Read More
Afamelanotide gains FDA and EMA orphan status for benign familial pemphigus
Read More
FDA confirms no association between Fluzone and febrile seizures
Read More
FDA grants breakthrough therapy designation to elotuzumab
Read More
Shire to submit an NDA to the FDA for lifitegrast
Read More
Ventrus Biosciences and Assembly Pharmaceuticals in merger agreement
Read More
Clovis Oncology's CO-1686 awarded breakthrough therapy designation
Read More
Hanmi initiates phase I trial of dual glucagon and GLP-1 receptor agonist
Read More
European conditional MAAs withdrawn for vintafolide and companion imaging agents
Read More
AstraZeneca rejects Pfizer's final proposal
Read More